Low-Dose Tirzepatide Improves Metabolic Health in Psoriasis and Obesity, suggests study Jacinthlyn Sylvia18 Jun 2026 10:15 PM ISTA new study published in the journal of Dermatology and Therapy showed that treatment with low-dose tirzepatide was linked to clinically significant...
Mounjaro Beats Ozempic-Class Drugs in Early Type 2 Diabetes Trial sheeba farhat1 Jun 2026 10:52 PM ISTLondon: Recently diagnosed type 2 diabetes patients who did not respond well to a usual first-line treatment fared better after adding Eli Lilly's...
Tirzepatide Superior to Intensified Conventional Care in Early Type 2 Diabetes: Trial Reveals Dr Kartikeya Kohli1 Jun 2026 11:00 AM ISTUSA: In a recent randomized controlled trial, Tirzepatide demonstrated significantly greater improvements than intensified conventional care (ICC) in...
Which patients benefit most from tirzepatide GLP-1 for obesity and OSA? Dr. Kamal Kant Kohli1 Jun 2026 1:00 AM ISTTirzepatide GLP-1 medication is known to improve sleep apnea for people with both obstructive sleep apnea (OSA) and obesity, but not all patients...
Retatrutide Shows Remarkable Weight Loss in Phase 3 TRIUMPH-1 Trial Dr Kartikeya Kohli23 May 2026 8:45 AM ISTIn the phase 3 TRIUMPH-1 trial, 2339 adults with obesity or overweight and at least one weight-related comorbidity were randomized to receive...
Combined Tirzepatide and Ixekizumab Therapy Shows Dual Benefits in Psoriasis: JAMA Medha Baranwal17 May 2026 9:15 PM ISTUSA: A clinical trial has found that combining tirzepatide with ixekizumab led to significant improvements in skin clearance and weight reduction in...
Oral Orforglipron Helps Maintain Weight Loss After Injectable Obesity Drugs-ATTAIN-MAINTAIN trial Dr Kartikeya Kohli15 May 2026 9:30 AM ISTNew research presented at the European Congress on Obesity 2026 and published in Nature Medicine found that most weight loss achieved with injectable...
Continuing Tirzepatide Greatly Improves Weight-Loss Maintenance, suggests study Dr Kartikeya Kohli14 May 2026 9:45 AM ISTNew research presented at this year's European Congress on Obesity (ECO 2026) in Istanbul, Turkey (12-15 May) and published in The Lancet shows that...
Eli Lilly Halts India Obesity Campaign After CDSCO Flags Indirect Promotion of Mounjaro MD Bureau12 May 2026 9:07 PM ISTHyderabad: Eli Lilly paused its obesity awareness campaign in India after the nation's drugs regulator warned the company it could violate rules...
Torrent Emerges Early Leader in India's Generic Semaglutide Race with 38% Market Share: Report Susmita Roy9 May 2026 5:23 PM ISTNew Delhi: Ahmedabad-based drug maker Torrent Pharma has emerged as the early frontrunner in India's fast-expanding generic semaglutide market,...
USFDA Says No Clinical Need to Compound GLP-1 Drugs, Novo Nordisk, Eli Lilly Stocks Jump sheeba farhat1 May 2026 10:00 AM ISTNew York: The U.S. Food and Drug Administration (USFDA) on ​Thursday proposed excluding Novo Nordisk and Eli Lilly's weight-loss drugs from a key...
